Lactose (India) Ltd. (BSE: 524202) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹133 Cr, it ranks #3,016 by market cap among the 6,137 Indian listed companies on FinBizNet, and #66 of 86 in Medicinal Chemicals and Botanical Products. At ₹99.50 (as of 25 Oct 2026), the share price is 27.1% below its 52-week high of ₹136.45 and 30.9% above its 52-week low of ₹76.01. The share price is down 16.1% over one year and down 0.5% over three months.
| Current Price | ₹99.50 |
|---|---|
| Market Cap | ₹133 Cr |
| BSE Code | 524202 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 22.6 |
| Return on Equity | 9.82% |
| Return on Assets | 5.00% |
| 52-Week Range | ₹76.01 – ₹136.45 |
| 1-Year Price Change | -16.1% |
| 3-Month Price Change | -0.5% |
| Beta (1Y) | 0.21 |
| Headquarters | Mumbai, Maharashtra |
| Website | www.lactoseindialimited.com |
Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India and internationally. The company offers lactose monohydrate; solid dosage forms comprising dry granulated, film, and lacquer coated tablets, as well as uncoated and blister packed solid dose forms; and liquid dosage forms. It also provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as well as for use as a prebiotic. In addition, the company exports its products. Lactose (India) Limited was incorporated in 1991 and is headquartered in Mumbai, India.
1. Pharmaceuticals-This segment manufactures and trades in pharmaceutical products. 2. Segment Adjustment-This segment offers textile products. 3. Project Export-0 4. Textile-0
1. Manufacturing & Trading of Pharmaceutical Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,21,995 Cr | 36.4 | 14.72% | ₹15,300 Cr | +5.4% |
| Zydus Lifesciences Ltd | ₹1,12,020 Cr | 22.2 | 18.32% | ₹8,017 Cr | +14.7% |
| Laurus Labs Ltd | ₹1,11,310 Cr | 125.3 | 17.74% | ₹2,026 Cr | +125.7% |
| Cipla Limited | ₹1,07,048 Cr | 27.6 | 11.74% | ₹7,119 Cr | -14.7% |
| Dr.Reddys Lab | ₹1,02,611 Cr | 24.1 | 11.52% | ₹8,698 Cr | -0.9% |
| Aurobindo Pharma Ltd. | ₹95,910 Cr | 26.8 | 9.93% | ₹9,150 Cr | +41.7% |
| Mankind Pharma | ₹93,977 Cr | 48.7 | 12.45% | ₹4,031 Cr | -9.9% |
| Lupin Ltd | ₹89,426 Cr | 16.6 | 26.91% | ₹8,277 Cr | -1.1% |
| Lactose (India) Ltd. | ₹133 Cr | 22.6 | 9.82% | — | -16.1% |
Listed by market capitalisation. Ratios are shown for context only.
Lactose (India) Ltd. is trading at ₹99.50, with a market capitalisation of ₹133 Cr.
Lactose (India) Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Lactose (India) Ltd. has a P/E of 22.6 and a return on equity of 9.82%.
Lactose (India) Ltd. is listed on the BSE under the scrip code 524202.
Lactose (India) Ltd.'s share price is down 16.1% over one year and down 0.5% over three months. Its 52-week range is ₹76.01 to ₹136.45.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.